Anne Mcgeorge
Director · 3 filings · Latest: Aug 10, 2026
Dianthus Therapeutics, Inc. /DE/
Oncology Institute, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
DNTH | Anne Mcgeorge | Director | Aug 10, 2026 | Sale | $109.01 | 7,750 | $844.8K | 0 | |
DNTH | Anne Mcgeorge | Director | Aug 10, 2026 | Option Exercise | $12.52 | 7,750 | $97.0K | 7,750 | |
DNTH | ANNE M MCGEORGE | — | Aug 10, 2026 | Proposed Sale | $108.92 | 7,750 | $844.1K | — | |